Oral administration of nicorandil enhances the survival of ischemic skin flaps in rats

European Journal of Pharmacology

Volumn 550, Issue 1-3, 2006, Pages 127-133

  Qi, Zhi ^a   Hiura, Akihito ^a   Nakagawa, Norimi ^a   Koga, Mari ^a   Yanai, Goichi ^a   Sumi, Shoichiro ^a   Inoue, Kazutomo ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Ischemic skin flap; KATP channel; Nicorandil; Survival rate

Indexed keywords

NICORANDIL;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG EFFECT; HISTOPATHOLOGY; ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN FLAP SURVIVAL; SKIN NECROSIS; SURVIVAL RATE; TISSUE BLOOD FLOW; TREATMENT OUTCOME;

ANIMALS; ISCHEMIA; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; NICORANDIL; RATS; RATS, WISTAR; REGIONAL BLOOD FLOW; SKIN; SURGICAL FLAPS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASODILATOR AGENTS;

EID: 33750014811     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.08.029     Document Type: Article

References (30)

1. Akao M., Teshima Y., and Marban E. Antiapoptotic effect of nicorandil mediated by mitochondrial atp-sensitive potassium channels in cultured cardiac myocytes. J. Am. Coll. Cardiol. 40 (2002) 803-810
2. Alizadeh N., Pittet B., Tenorio X., Pyke C., Baetens D., Schlaudraff K.U., Montandon D., Ezban M., and Pepper M.S. Active-site inactivated FVIIa decreases thrombosis and necrosis in a random skin flap model of acute ischemia. J. Surg. Res. 122 (2004) 263-273
3. Ashrafpour H., Huang N., Neligan P.C., Forrest C.R., Addison P.D., Moses M.A., Levine R.H., and Pang C.Y. Vasodilator effect and mechanism of action of vascular endothelial growth factor in skin vasculature. Am. J. Physiol, Heart Circ. Physiol. 286 (2004) 946-954
4. Date T., Taniguchi I., Inada K., Matsuo S., Miyanaga S., Yamane T., Abe Y., Sugimoto K., and Mochizuki S. Nicorandil inhibits serum starvation-induced apoptosis in vascular endothelial cells. J. Cardiovasc. Pharmacol. 46 (2005) 721-726
5. Ercocen A.R., Kono T., Kikuchi Y., Kitazawa Y., and Nozaki M. Efficacy of the flashlamp-pumped pulsed-dye laser in nonsurgical delay of skin flaps. Dermatol. Surg. 29 (2003) 692-699
6. Hai S., Takemura S., Minamiyama Y., Yamasaki K., Yamamoto S., Kodai S., Tanaka S., Hirohashi K., and Suehiro S. Mitochondrial K (ATP) channel opener prevents ischemia-reperfusion injury in rat liver. Transplant. Proc. 37 (2005) 428-431
7. Hausenloy D.J., Yellon D.M., Mani-Babu S., and Duchen M.R. Preconditioning protects by inhibiting the mitochondrial permeability transition. Am. J. Physiol, Heart Circ. Physiol. 287 (2004) 841-849
8. Hayashi Y., Sawa Y., Ohtake S., Nishimura M., Ichikawa H., and Matsuda H. Controlled nicorandil administration for myocardial protection during coronary artery bypass grafting under cardiopulmonary bypass. J. Cardiovasc. Pharmacol. 38 (2001) 21-28
9. Hijjawi J., Mogford J.E., Chandler L.A., Cross K.J., Said H., Sosnowski B.A., and Mustoe T.A. Platelet-derived growth factor B, but not fibroblast growth factor 2, plasmid DNA improves survival of ischemic myocutaneous flaps. Arch. Surg. 139 (2004) 142-147
10. Hongo M., Mawatari E., Sakai A., Ruan Z., Koizumi T., Terasawa F., Yazaki Y., Kinoshita O., Ikeda U., and Shibamoto T. Effects of nicorandil on monocrotaline-induced pulmonary arterial hypertension in rats. J. Cardiovasc. Pharmacol. 46 (2005) 452-458
11. Hsu O.K., Gabr E., Steward E., Chen H., Kobayashi M.R., Calvert J.W., Sundine M.J., Kotchounian T., Dhar S., and Evans G.R. Pharmacologic enhancement of rat skin flap survival with topical oleic acid. Plast. Reconstr. Surg. 113 (2004) 2048-2054
12. Huemer G.M., Wechselberger G., Otto-Schoeller A., Gurunluoglu R., Piza-Katzer H., and Schoeller T. Improved dorsal random-pattern skin flap survival in rats with a topically applied combination of nonivamide and nicoboxil. Plast. Reconstr. Surg. 111 (2003) 1207-1211
13. Imagawa J., Baxter G.F., and Yellon D.M. Myocardial protection afforded by nicorandil and ischaemic preconditioning in a rabbit infarct model in vivo. J. Cardiovasc. Pharmacol. 31 (1998) 74-79
14. Iwai T., Tanonaka K., Motegi K., Inoue R., Kasahara S., and Takeo S. Nicorandil preserves mitochondrial function during ischemia in perfused rat heart. Eur. J. Pharmacol. 446 (2002) 119-127
15. Kara I.G., Kara C.O., Ozden A., and Ocsel H. The effect of trimetazidine on the survival of rat island skin flaps subjected to ischemia-reperfusion injury. Ann. Plast. Surg. 47 (2001) 168-171
16. Karaçal N., Ambarcioǧlu Ö., Topal U., Mamedov T., and Kutlu N. Enhancement of dorsal random-pattern skin flap survival in rats with topical lidocaine and prilocaine (EMLA): enhancement of flap survival by EMLA. J. Surg. Res. 124 (2005) 134-138
17. Kjartansson J., Lundeberg T., Samuelson U.E., and Dalsgaard C.J. Transcutaneous electrical nerve stimulation (TENS) increases survival of ischaemic musculocutaneous flaps. Acta Physiol. Scand. 134 (1988) 95-99
18. Kryger Z., Zhang F., Dogan T., Cheng C., Lineaweaver W.C., and Buncke H.J. The effects of VEGF on survival of a random flap in the rat: examination of various routes of administration. Br. J. Plast. Surg. 53 (2000) 234-239
19. Kubulus D., Roesken F., Amon M., Rucker M., Bauer M., Bauer I., and Menger M.D. Mechanism of the delay phenomenon: tissue protection is mediated by hemeoxygenase-1. Am. J. Physiol, Heart Circ. Physiol. 287 (2004) 2332-2340
20. Mcfarlane R.M., De Young G., and Henry R.A. The design of a pedicle flap in the rat to study necrosis and its prevention. Plast. Reconstr. Surg. 35 (1965) 177-182
21. Nagata K., Obata K., Odashima M., Yamada A., Somura F., Nishizawa T., Ichihara S., Izawa H., Iwase M., Hayakawa A., Murohara T., and Yokota M. Nicorandil inhibits oxidative stress-induced apoptosis in cardiac myocytes through activation of mitochondrial ATP-sensitive potassium channels and a nitrate-like effect. J. Mol. Cell. Cardiol. 35 (2003) 1505-1512
22. Rinsch C., Quinodoz P., Pittet B., Alizadeh N., Baetens D., Montandon D., Aebischer P., and Pepper M.S. Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemia. Gene Ther. 8 (2001) 523-533
23. Sumi S., Inoue K., Minote H., Hosotani R., Doi R., Kaji H., Yun M., Fujii N., and Yobe T. Effect of synthetic Des-1-Ala-des alpha-amino chicken CGRP a derivative of calcitonin gene-related peptide, on ischemic skin flap in rats. Neuropeptides 10 (1991) 55-60
24. Taira N. Similarity and dissimilarity in the mode and mechanism of action between nicorandil and classical nitrates: an overview. J. Cardiovasc. Pharmacol. 10 (1987) 1-9
25. Taran A., Har-Shai Y., Lindenbaum E., Ullmann Y., Beach D., Tendler M., Barak A., and Peled I.J. Improved vitality of experimental random dorsal skin flaps in rats treated with enriched cell culture medium. Plast. Reconstr. Surg. 104 (1999) 148-151
26. Teshima Y., Akao M., Baumgartner W.A., and Marban E. Nicorandil prevents oxidative stress-induced apoptosis in neurons by activating mitochondrial ATP-sensitive potassium channels. Brain Res. 990 (2003) 45-50
27. The IONA Study Group. Trial to show the impact of nicorandil in angina (IONA): design, methodology, and management. Heart 85 (2001) 9-16
28. Ueda K., Goto C., Jitsuiki D., Umemura T., Nishioka K., Kimura M., Noma K., Nakagawa K., Oshima T., Yoshizumi M., Chayama K., and Higashi Y. The nicorandil-induced vasodilation in humans is inhibited by miconazole. J. Cardiovasc. Pharmacol. 45 (2005) 290-294
29. ATP channel opener, on coronary capillary architecture and volume after early myocardial ischemia-reperfusion. A 3-dimensional confocal laser microscopic study. Circ. J. 68 (2004) 1210-1214
30. Yokota M., Horisawa T., Iwase M., Miyahara T., Yoshida J., Kamihara S., Noda S., Tsunekawa A., Koide M., and Tsuzuki M. Effects of a new vasodilator, nicorandil, on exercise induced impairment of left ventricular function in patients with old myocardial infarction. J. Cardiovasc. Pharmacol. 10 (1987) 116-122